Table 3.
Unadjusted odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | |
---|---|---|---|---|
Site status | ||||
| ||||
Control | 1 | ·· | 1 | ·· |
Intervention | 3.22 (1.02–10.22) | 0.047 | 3.18 (1.02–9.87) | 0.05 |
| ||||
Age group (years) | ||||
| ||||
<15 | 0.90 (0.74–1.08) | 0.25 | 0.97 (0.78–1.21) | 0.81 |
15–24 | 1.25 (0.91–1.74) | 0.17 | 1.38 (1.24–1.53) | <0.0001 |
25–49 | 1.32 (1.18–1.46) | <0.0001 | 1.47 (1.08–1.99) | 0.013 |
≥50 | 1 | ·· | 1 | ·· |
| ||||
Sex | ||||
| ||||
Male | 1.11 (1.04–1.19) | 0.0016 | 1.16 (1.09–1.24) | <0.0001 |
Female | 1 | ·· | 1 | ·· |
| ||||
Marital status | ||||
| ||||
Married | 1.21 (0.98–1.51) | 0.077 | ·· | ·· |
Divorced or separated | 1.31 (1.14–1.52) | 0.0003 | ·· | ·· |
Widow | 1 | ·· | ·· | ·· |
Single | 0.93 (0.84–1.03) | 0.18 | ·· | ·· |
| ||||
WHO stage | ||||
| ||||
I | 1 | ·· | 1 | ·· |
II | 1.67 (1.34–2.09) | <0.0001 | 1.62 (1.58–1.67) | <0.0001 |
III | 1.68 (1.57–1.80) | <0.0001 | 1.64 (1.30–2.06) | <0.0001 |
IV | 1.47 (0.91–2.40) | 0.12 | 1.37 (0.89–2.12) | 0.15 |
| ||||
Baseline CD4 category (cells per μL) | ||||
| ||||
<350 | 3.27 (2.87–3.73) | <0.0001 | ·· | ·· |
350–500 | 2.85 (1.69–4.82) | <0.0001 | ·· | ·· |
>500 | 1 | ·· | ·· | ·· |
| ||||
Transfer out | ||||
| ||||
No | 1.25 (0.79–1.97) | 0.34 | ·· | ·· |
Yes | 1 | ·· | ·· | ·· |
| ||||
First-line regimen | ||||
| ||||
Nevirapine | 1.85 (1.37–2.52) | <0.0001 | ·· | ·· |
Efavirenz | 1.41 (0.89–2.22) | 0.14 | ·· | ·· |
| ||||
ART adherence | ||||
| ||||
Satisfactory | 1.59 (0.67–3.79) | 0.29 | ·· | ·· |
Unsatisfactory | 1 | ·· | ·· | ·· |
ART=antiretroviral therapy.